pretickt

Is LHX a good stock to buy?

L3Harris Technologies, Inc. · end-of-day data as of Nov 13, 2026

L3Harris
LHX · $50.71B
$272.35+0.2%
Nov 13, 2026 · close
$240$260$280SepOctNov9:3016:003 months -2.1%Nov 13 · close
▲ 7
  • PT$343.17 +26.0%
  • ConsensusBuy · 23
  • P/E vs own-19.9%
  • FCF yield+7.2%
  • MAs3 of 4
  • MA20×50Golden 9d ago
  • MACD0.45
Neutral
  • Earnings in76d
  • P/E25.4x
  • RSI60
  • Support-2.5%
  • Resistance+1.7%
  • Off 52w high-28.2%
  • Volume0.5x
  • Bollingerupper half
  • News0.00
  • P/E vs sector-7.2%
  • 52w range$232–$379
  • ATR+2.7%
  • Off ATH-28.2%
  • InsidersNone in 90d
▼ 2
  • Trendbearish
  • Sector▼ -11.7%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is L3Harris a good stock to buy?

L3Harris is strong on 3 of the 5 questions about the business; weak on advantage. The price is low: 25.4 times its earnings, below its 3-year median of 32.3 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand growing
  2. Advantage easy to copy
  3. Economics profits growing
  4. Execution delivers
  5. Fragility some risks
  6. Price below its usual
DemandDo people want more of what it sells?growing

LHX sales growth revenue growth

+9%a year, for the last 3 years

L3Harris' sales grew 9% a year for 3 years, to $21.86B in fiscal 2025.

LHX analysts' forecast revenue estimates

+8%the sales they expect next fiscal year, on the last

Analysts expect L3Harris' sales to grow 8% to $23.63B in fiscal 2026 (16 analysts).

LHX competitors

pretickt analysis+7%its sales in 12 months, on a year before

L3Harris' sales grew 7% in the 12 months to Oct 2, 2026, slower than Rocket Lab (+59%), HEICO (+21%) and TransDigm (+20%).

LHX sales by business revenue by segment

31%of its sales from Space and Airborne Systems

Space and Airborne Systems brought L3Harris 31% of its sales in fiscal 2025; Integrated Mission Systems 30%.

Advantage moatIs it hard to copy?easy to copy

LHX margin on each sale gross margin

26%left after making the product

L3Harris kept 26% of each sale after making the product in the 12 months to Oct 2, 2026; its competitors' median is 38%.

EconomicsDoes it make good money?profits growing

LHX cash generated free cash flow

$3.64Bcash left after investing, last 12 months

L3Harris generated $3.64B of free cash flow in the 12 months to Oct 2, 2026, more than its reported profit.

LHX profit per share

+8%in its last fiscal year

L3Harris' earnings per share grew 8% in fiscal 2025, to $8.53.

ExecutionDoes it deliver what it promises?delivers

LHX earnings vs estimates

8 of 8quarters above the analysts' estimate

L3Harris beat the analysts' profit estimate in each of its last 8 quarters, the latest on Oct 29, 2026.

LHX insider selling

-$7.5Msold, net, by its executives in 12 months

L3Harris' executives and directors sold a net $7.5M of shares in the 12 months to Nov 13, 2026; none bought.

LHX number of employees

-4%fewer people in a year

L3Harris had 45,000 employees at the end of fiscal 2025, 4% fewer than a year before.

LHX CEO pay

$25.62Mfor fiscal 2025, 57% of it in stock and options

L3Harris paid its CEO $25.62M for fiscal 2025, 57% of it in stock and options.

Fragility risksCould something break it?some risks

LHX financial health Altman Z-score

2.3Altman Z-score, safe above 3

L3Harris' Altman Z-score is 2.3 (Nov 13, 2026), between 1.8 and 3, the grey zone.

LHX quality checks Piotroski score

8 of 9checks passed

L3Harris passes 8 of the 9 Piotroski checks in the 12 months to Oct 2, 2026; it misses on gross margin.

LHX biggest customers

75%of sales from its biggest customer

U.S. Government made 75% of L3Harris' sales in fiscal 2025.

LHX shareholders institutional ownership

pretickt analysis
  • Vanguard11.6% ▲
  • BlackRock10.2% ▲
  • State Street4.9% ▲
1,750institutions hold it; the largest added shares

1,750 institutions hold 88% of L3Harris' shares (Jun 30, 2026); Vanguard, BlackRock and State Street added shares that quarter.

Price valuationIs the price reasonable?below its usual

LHX price vs profit P/E ratio

25.4×a year's earnings

L3Harris' P/E ratio is 25.4 (Nov 13, 2026), below its 3-year median of 32.3.

LHX price vs competitors

pretickt analysis25.4×a year's earnings, against its competitors

Investors pay 25.4 times L3Harris' earnings (Nov 13, 2026), less than for HEICO (56.7), TransDigm (34.3) or Honeywell Aerospace (27.5).

LHX analysts' target price target

+26%to their average target

Analysts' average price target for L3Harris is $343, 26% above the Nov 13, 2026 close of $272.35.

LHX growth priced in fair value

pretickt analysis+2%a year, for ten years, to be worth the price

At $272.35 a share, L3Harris' free cash flow must grow about 2% a year for ten years to be worth the price (Nov 13, 2026).

What is L3Harris' P/E ratio?

L3Harris' P/E ratio is 25.4 (Nov 13, 2026), below its 3-year median of 32.3. Investors pay 25.4 times L3Harris' earnings (Nov 13, 2026), less than for HEICO (56.7), TransDigm (34.3) or Honeywell Aerospace (27.5).

Who are L3Harris' biggest competitors?

pretickt compares L3Harris with Honeywell Aerospace, HEICO, Rocket Lab and TransDigm. L3Harris' sales grew 7% in the 12 months to Oct 2, 2026, slower than Rocket Lab (+59%), HEICO (+21%) and TransDigm (+20%).

Are insiders selling L3Harris stock?

L3Harris' executives and directors sold a net $7.5M of shares in the 12 months to Nov 13, 2026; none bought.

How does L3Harris make money?

Space and Airborne Systems brought L3Harris 31% of its sales in fiscal 2025; Integrated Mission Systems 30%.

Who owns L3Harris stock?

1,750 institutions hold 88% of L3Harris' shares (Jun 30, 2026); Vanguard, BlackRock and State Street added shares that quarter.

How many employees does L3Harris have?

L3Harris had 45,000 employees at the end of fiscal 2025, 4% fewer than a year before.

Who are L3Harris' biggest customers?

U.S. Government made 75% of L3Harris' sales in fiscal 2025.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.